GROUP investigators include: René S. Kahn(1), Don Linszen(2), Jim van Os(3), Durk Wiersma(4), Richard Bruggeman(4), Wiepke Cahn(1), Lieuwe de Haan(2), Lydia Krabbendam(3), and Inez Myin-Germeys(3); 1. Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, TheNetherlands; 2. Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 3 Mental Health Research and Teaching Network, Maastricht University Medical Center, South Limburg, Maastricht, The Netherlands; 4. Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Letter to the Editor
Replication and refinement of the role of rs548181 in schizophrenia: Results from a family based study†
Article first published online: 28 NOV 2012
Copyright © 2012 Wiley Periodicals, Inc.
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Volume 162, Issue 1, pages 75–77, January 2013
How to Cite
Derks, E. M., Ophoff, R. A. and Genetic Risk Outcome of Psychosis (GROUP) (2013), Replication and refinement of the role of rs548181 in schizophrenia: Results from a family based study. Am. J. Med. Genet., 162: 75–77. doi: 10.1002/ajmg.b.32120
How to Cite this Article: Derks EM, Ophof RA, Genetic Risk and Outcome of Psychosis (GROUP). 2012. Replication and Refinement of the Role of rs548181 in Schizophrenia: Results From a Family Based Study. Am J Med Genet Part B 162B:75–77.
- Issue published online: 18 DEC 2012
- Article first published online: 28 NOV 2012
- Manuscript Accepted: 5 NOV 2012
- Manuscript Received: 29 MAR 2012
- NIMH. Grant Numbers: RO1, HO78075
- Geestkracht Program of the Dutch Health Research Council. Grant Numbers: ZON-MW, 10-000-1002
- EU Seventh Framework Program (EU-GEI)
- Mental Health Care Academic Organizations AMC Amsterdam Netherlands Scientific Organization (NWO). Grant Number: 451-080-010